The second annual America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), a forum for clinicians, researchers and other MS specialists to network and discuss the latest advances in MS research and treatment is set for February 23 to 25, 2017.
As we did in 2016, the Multiple Sclerosis News Today team will be offering coverage of the event. ACTRIMS 2016 had some hot topics about MS and MS research that were very much appreciated by the whole multiple sclerosis community.
To help you prepare for ACTRIMS 2017, we’ve put a list together of the hottest topics from last year’s conference:
1. Stem cells and multiple sclerosis at ACTRIMS 2016.
In this MSWorld video, watch Dr. Daniel Kantor talk with Dr. Michael Racke, Professor of Neurology and Neurosciences at Ohio State University about stem cells and multiple sclerosis, and how this treatment option can be used to help patients with MS.
2. Genetics and multiple sclerosis at ACTRIMS 2016.
In this MSWorld video, Dr. Daniel Kantor talks with Dr. Philip De Jager, Associate Professor of Neurology at Harvard Medical School about genetics and multiple sclerosis. Could genetics be related to the development of MS? How does this disease develop and evolve?
3. The differences between relapsing and progressive forms of MS at ACTRIMS 2016.
In this video from MSWorld, learn more about the differences between relapsing and progressive forms of multiple sclerosis. Dr. Daniel Kantor talks with Dr. Jay Rosenberg, Dr. Jonathan Calkwood, Dr. Heidi Crayton and Dr. Samuel Hunter, to understand more about the disease, its forms, how they differ from each other and how patients are affected.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?